IJH Volume 121, Issue 1, January 2025 is now available. JSH members can access the full text. A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes CD34+ and CD34− MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34+ MM cells and more!
